CVS HEALTH Corp FY 2025 10-K, explained in plain English
Key financials — as reported
| Total revenue | $402.1B |
| Gross margin | 45.0% |
| Operating income | $4.7B |
| Net income | $1.8B |
| Diluted EPS | $1.39 |
| Cash & equivalents | $8.5B |
| Total assets | $253.5B |
| Long-term debt | $60.5B |
Key takeaway
CVS reported $402.1 billion in revenue but only $1.77 billion in net income, indicating significant cost or expense pressure eating into margins.
🔒 4 more takeaways in the full analysis
Beneath the surface
The effective tax rate reconciliation includes unusual offsetting items—a -83.9% impact from a business disposition and +56.3% from nondeductible impairment losses—suggesting one-time events materially distorted the tax rate and possibly net income, masking underlying operating performance.
🔒 3 more insights a headline reader would miss
This is the free preview. The full analysis explains every line item above and includes 7 more findings — plus insider trades, activist stakes, and 8-K events for CVS.
Read the full analysis free Free account · 5 full analyses included · no card required